Showcasing our AI-powered digital cytotoxicity and cell viability assay, we demonstrate how Nanolive’s high-content live cell imaging can be used to increase confidence in lead candidate selection.
In this webinar, we explore the following drug discovery applications of Nanolive’s LIVE Cell Death Assay – all completely label-free:
Cell Death
- Drug screening in a 96-well plate
- Differentiating between necrotic and apoptotic cell death
- Detecting therapy resistance
Cell Health, Stress and Recovery
- Detecting cell stress before death
- Investigating therapy resistance using the Health Cell Index and Refractive Index imaging
- Monitoring cell recovery from the apoptotic pathway (anastasis)
Speaker: Hope Amos
Scientific Communication Specialist
Read our latest news
Newsletter November 2024: Techniques for high-content live cell imaging
Welcome to the November edition of the AI for Live Cell Insights Newsletter, bringing you the latest live cell analyses powering drug discovery and cosmetics development. Each month, we will explore applications of AI-based cellular analysis for label-free live cell...
Newsletter October 2024: Investigative toxicology without labels
Welcome to the October edition of the AI for Live Cell Insights Newsletter, bringing you the latest live cell analyses powering drug discovery and cosmetics development. Each month, we will explore a new application of AI-based cellular analysis for label-free live...
September 2024: High-content imaging for kidney disease research
Welcome to the September edition of the AI for Live Cell Insights Newsletter, bringing you the latest live cell analyses powering drug discovery and cosmetics development. Each month, we will explore a new application of cellular analysis for label-free live cell...